<VariationArchive VariationID="370898" VariationName="NM_002485.5(NBN):c.317dup (p.Arg107fs)" VariationType="Duplication" Accession="VCV000370898" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2017-01-06" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357669" VariationID="370898">
      <GeneList>
        <Gene Symbol="NBN" FullName="nibrin" GeneID="4683" HGNC_ID="HGNC:7652" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="89933331" stop="89984667" display_start="89933331" display_stop="89984667" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="90945563" stop="90996898" display_start="90945563" display_stop="90996898" Strand="-" />
          </Location>
          <OMIM>602667</OMIM>
          <Haploinsufficiency last_evaluated="2020-08-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NBN">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-08-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NBN">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002485.5(NBN):c.317dup (p.Arg107fs)</Name>
      <CanonicalSPDI>NC_000008.11:89981377:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="89981377" stop="89981378" display_start="89981377" display_stop="89981378" variantLength="1" positionVCF="89981377" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="90993605" stop="90993606" display_start="90993605" display_stop="90993606" variantLength="1" positionVCF="90993605" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>R107fs</ProteinChange>
      <ProteinChange>R25fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.90993607dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.90993607dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.89981379dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.89981379dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008860.1" sequenceAccession="NG_008860" sequenceVersion="1" change="g.8294dup">
            <Expression>NG_008860.1:g.8294dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024688.3" sequenceAccession="NM_001024688" sequenceVersion="3" change="c.71dup">
            <Expression>NM_001024688.3:c.71dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001019859.1" sequenceAccession="NP_001019859" sequenceVersion="1" change="p.Arg25fs">
            <Expression>NP_001019859.1:p.Arg25fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002485.5" sequenceAccession="NM_002485" sequenceVersion="5" change="c.317dup" MANESelect="true">
            <Expression>NM_002485.5:c.317dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002476.2" sequenceAccession="NP_002476" sequenceVersion="2" change="p.Arg107fs">
            <Expression>NP_002476.2:p.Arg107fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_158" sequenceAccession="LRG_158">
            <Expression>LRG_158:g.8294dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_158t1" sequenceAccession="LRG_158t1">
            <Expression>LRG_158t1:c.317dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_158p1" sequenceAccession="LRG_158p1" change="p.Arg107fs">
            <Expression>LRG_158p1:p.Arg107fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002485.4" sequenceAccession="NM_002485" sequenceVersion="4" change="c.317dupT">
            <Expression>NM_002485.4:c.317dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA4803012" DB="ClinGen" />
        <XRef Type="rs" ID="745355767" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002485.5(NBN):c.317dup (p.Arg107fs) AND Microcephaly, normal intelligence and immunodeficiency" Accession="RCV000409799" Version="11">
        <ClassifiedConditionList TraitSetID="1916">
          <ClassifiedCondition DB="MedGen" ID="C0398791">Microcephaly, normal intelligence and immunodeficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-12-10" SubmissionCount="4">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002485.5(NBN):c.317dup (p.Arg107fs) AND multiple conditions" Accession="RCV002505995" Version="3">
        <ClassifiedConditionList TraitSetID="13698">
          <ClassifiedCondition DB="MedGen" ID="C0023449">Acute lymphoid leukemia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0002874">Aplastic anemia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0398791">Microcephaly, normal intelligence and immunodeficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-10" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-01-06" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16415040</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9590180</ID>
        </Citation>
        <DescriptionHistory Dated="2020-06-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13698" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6569" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Acute lymphoid leukemia</ElementValue>
                <XRef ID="Acute+Lymphoblastic+Leukemia/188" DB="Genetic Alliance" />
                <XRef ID="91857003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute lymphoblastic, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute lymphoblastic leukemia</ElementValue>
                <XRef ID="HP:0006721" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0004967" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute lymphocytic leukemia</ElementValue>
                <XRef ID="HP:0006721" DB="Human Phenotype Ontology" />
                <XRef ID="128822004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lymphoblastic leukemia</ElementValue>
                <XRef ID="MONDO:0001018" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALL</ElementValue>
                <XRef Type="MIM" ID="613065" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="522" />
                <XRef ID="522" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/all.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2024</CitationText>
              </Citation>
              <XRef ID="513" DB="Orphanet" />
              <XRef ID="C0023449" DB="MedGen" />
              <XRef ID="MONDO:0004967" DB="MONDO" />
              <XRef Type="MIM" ID="613065" DB="OMIM" />
              <XRef Type="primary" ID="HP:0006721" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004803" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005555" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="3184" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nijmegen breakage syndrome</ElementValue>
                <XRef ID="MONDO:0009623" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Berlin Breakage syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microcephaly with normal intelligence immunodeficiency and lymphoreticular malignancies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromal microcephaly autosomal recessive with normal intelligence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Seemanova syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Microcephaly, normal intelligence and immunodeficiency</ElementValue>
                <XRef ID="Microcephaly+with+normal+intelligence%2C+immunodeficiency/4760" DB="Genetic Alliance" />
                <XRef ID="234638009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency, microcephaly with normal intelligence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SEEMANOVA SYNDROME II</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY, MICROCEPHALY, AND CHROMOSOMAL INSTABILITY</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia telangiectasia variant V1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBS</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BBS</ElementValue>
                <XRef ID="251260" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AT-V1</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Nijmegen breakage syndrome (NBS) is characterized by progressive microcephaly, early growth deficiency that improves with age, recurrent respiratory infections, an increased risk for malignancy (primarily lymphoma), and premature ovarian failure in females. Developmental milestones are attained at the usual time during the first year; however, borderline delays in development and hyperactivity may be observed in early childhood. Intellectual abilities tend to decline over time. Recurrent pneumonia and bronchitis may result in respiratory failure and early death. Other reported malignancies include solid tumors (e.g., medulloblastoma, glioma, rhabdomyosarcoma).</Attribute>
                <XRef ID="NBK1176" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3904" />
                <XRef ID="3904" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301355</ID>
                <ID Source="BookShelf">NBK1176</ID>
              </Citation>
              <XRef ID="647" DB="Orphanet" />
              <XRef ID="C0398791" DB="MedGen" />
              <XRef ID="MONDO:0009623" DB="MONDO" />
              <XRef Type="MIM" ID="251260" DB="OMIM" />
            </Trait>
            <Trait ID="4604" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aplastic anemia</ElementValue>
                <XRef ID="Aplastic+Anemia/556" DB="Genetic Alliance" />
                <XRef ID="HP:0001915" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0015909" DB="MONDO" />
                <XRef ID="306058006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20234" />
                <XRef ID="20234" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="182040" DB="Orphanet" />
              <XRef ID="88" DB="Orphanet" />
              <XRef ID="C0002874" DB="MedGen" />
              <XRef ID="MONDO:0015909" DB="MONDO" />
              <XRef Type="MIM" ID="609135" DB="OMIM" />
              <XRef Type="primary" ID="HP:0001915" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1916" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3184" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nijmegen breakage syndrome</ElementValue>
                <XRef ID="MONDO:0009623" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Berlin Breakage syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microcephaly with normal intelligence immunodeficiency and lymphoreticular malignancies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromal microcephaly autosomal recessive with normal intelligence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Seemanova syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Microcephaly, normal intelligence and immunodeficiency</ElementValue>
                <XRef ID="Microcephaly+with+normal+intelligence%2C+immunodeficiency/4760" DB="Genetic Alliance" />
                <XRef ID="234638009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency, microcephaly with normal intelligence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SEEMANOVA SYNDROME II</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY, MICROCEPHALY, AND CHROMOSOMAL INSTABILITY</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia telangiectasia variant V1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBS</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BBS</ElementValue>
                <XRef ID="251260" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AT-V1</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Nijmegen breakage syndrome (NBS) is characterized by progressive microcephaly, early growth deficiency that improves with age, recurrent respiratory infections, an increased risk for malignancy (primarily lymphoma), and premature ovarian failure in females. Developmental milestones are attained at the usual time during the first year; however, borderline delays in development and hyperactivity may be observed in early childhood. Intellectual abilities tend to decline over time. Recurrent pneumonia and bronchitis may result in respiratory failure and early death. Other reported malignancies include solid tumors (e.g., medulloblastoma, glioma, rhabdomyosarcoma).</Attribute>
                <XRef ID="NBK1176" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3904" />
                <XRef ID="3904" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301355</ID>
                <ID Source="BookShelf">NBK1176</ID>
              </Citation>
              <XRef ID="647" DB="Orphanet" />
              <XRef ID="C0398791" DB="MedGen" />
              <XRef ID="MONDO:0009623" DB="MONDO" />
              <XRef Type="MIM" ID="251260" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2672106" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_002485.4:c.317dup|MedGen:C0398791" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001363749" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: NBN c.317dupT (p.Arg107GlnfsX5) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.657_661delACAAA (p.Lys219fsX16), c.698_701delAACA (p.Lys233fsX5)). The variant allele was found at a frequency of 4e-06 in 251156 control chromosomes (gnomAD). To our knowledge, no occurrence of c.317dupT in individuals affected with Nijmegen Breakage Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NBN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002485.4:c.317dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Microcephaly, normal intelligence and immunodeficiency</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0398791" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="950077" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="906942|OMIM:251260" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000486327" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NBN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002485.4:c.317dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="251260" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4012183" SubmissionDate="2021-12-29" DateLastUpdated="2022-01-03" DateCreated="2022-01-03">
        <ClinVarSubmissionID localKey="NM_002485.5:c.317dup|OMIM:251260" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002045367" DateUpdated="2022-01-03" DateCreated="2022-01-03" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NBN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002485.5:c.317dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="251260" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10872261</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5454703" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_002485.5:c.317dup|OMIM:251260;609135;613065" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002803167" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002485.5:c.317dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="251260" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609135" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613065" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3111714" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4553879|MedGen:C0398791" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001586067" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9590180</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16415040</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg107Glnfs*5) in the NBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBN are known to be pathogenic (PMID: 9590180, 16415040). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 370898). This variant has not been reported in the literature in individuals affected with NBN-related conditions. This variant is present in population databases (rs745355767, gnomAD 0.003%).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NBN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.90993605_90993606insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0398791" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="950077" TraitType="Disease" MappingType="XRef" MappingValue="251260" MappingRef="OMIM">
        <MedGen CUI="C0398791" Name="Microcephaly, normal intelligence and immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5454703" TraitType="Disease" MappingType="XRef" MappingValue="613065" MappingRef="OMIM">
        <MedGen CUI="C0023449" Name="Acute lymphoid leukemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2672106" TraitType="Disease" MappingType="Name" MappingValue="Microcephaly, normal intelligence and immunodeficiency" MappingRef="Preferred">
        <MedGen CUI="C0398791" Name="Microcephaly, normal intelligence and immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5454703" TraitType="Disease" MappingType="XRef" MappingValue="609135" MappingRef="OMIM">
        <MedGen CUI="C0002874" Name="Aplastic anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5454703" TraitType="Disease" MappingType="XRef" MappingValue="251260" MappingRef="OMIM">
        <MedGen CUI="C0398791" Name="Microcephaly, normal intelligence and immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3111714" TraitType="Disease" MappingType="XRef" MappingValue="C0398791" MappingRef="MedGen">
        <MedGen CUI="C0398791" Name="Microcephaly, normal intelligence and immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4012183" TraitType="Disease" MappingType="XRef" MappingValue="251260" MappingRef="OMIM">
        <MedGen CUI="C0398791" Name="Microcephaly, normal intelligence and immunodeficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2023-09-30">SCV001341485</Accession>
        <Description>NBN_VCV000370898: Variant is no longer reported</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

